Product Information
PRAZOSIN 5 MG CAPSULE is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.1337 per EA under NDC 70010008601. Its NADAC has been published 239 times since Mar 9, 2022.
FDA first approved this application on Dec 23, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010008601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PRAZOSIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214608FDA Approved
12/23/2021
TE Code
AB
On Market Since
1/3/2022
Pharmacological Classes
Price Statistics
The NADAC for PRAZOSIN 5 MG CAPSULE has been published 239 times since Mar 9, 2022, and over the history we have for it it has declined 68.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1337 per EA |
|---|---|
| All-time high | $0.5386 (Apr 13, 2022) |
| All-time low | $0.1293 (Aug 19, 2026) |
| 52-week high | $0.1493 |
| 52-week low | $0.1293 |
| Median price | $0.2395 |
| Average price | $0.2917 |
| Largest weekly change | -41.3% (Nov 20, 2024) |
| Weeks tracked | 239 |
| Tracking since | Mar 9, 2022 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Granules Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Prazosin Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PRAZOSIN 5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PRAZOSIN 5 MG CAPSULE, manufactured by Granules Pharmaceuticals Inc., is $0.1337 per EA (NDC 70010008601), effective Sep 30, 2026.
How has the price of PRAZOSIN 5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PRAZOSIN 5 MG CAPSULE has declined 68.6%. It has been tracked across 239 weekly CMS publications since Mar 9, 2022.
What are the highest and lowest recorded NADAC prices for PRAZOSIN 5 MG CAPSULE?
Since Mar 9, 2022, the NADAC for PRAZOSIN 5 MG CAPSULE has ranged from a low of $0.1293 (Aug 19, 2026) to a high of $0.5386 (Apr 13, 2022), with a median of $0.2395 per EA.
Are there cheaper alternatives to PRAZOSIN 5 MG CAPSULE?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PRAZOSIN 5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures PRAZOSIN 5 MG CAPSULE?
PRAZOSIN 5 MG CAPSULE (NDC 70010008601) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.